Mauna Kea adds endomicroscope intelligence to robotic surgery toolkit
By John Brosky, Contributing Writer, BioWorld MedTech
PARIS – The Food and Drug Administration granted 510(k) clearance to Paris-based Mauna Kea Technologies SA to apply the Celioflex UHD confocal miniprobes in robotic-assisted surgery procedures.
The first utilization for a microscopic view during robotic surgery is expected to be for optical biopsies, enabling a surgeon to define margins around cancerous tissue in real time, Mauna Kea founder and CEO Sasha Loiseau told BioWorld MedTech.
